Stacey Ma, PhD, serves as Executive Vice President of Pharmaceutical Development and Manufacturing, with responsibility for all the company’s investigational compounds and marketed products.
Stacey joined Gilead in 2022 after more than two decades in the biopharmaceutical industry. Prior to Gilead, she served as Executive Vice President of Technical Operations at Sana Biotechnology and as Global Head of Innovation, Manufacturing Science and Technology at Genentech/Roche.
Stacey has a PhD in chemical engineering from Yale University and master’s and bachelor’s degrees in chemical engineering from Yale and the University of Minnesota, respectively.
She currently sits on the board of directors of Elanco Animal Health, an American pharmaceutical company focused on treating and preventing disease in pets and livestock in more than 90 countries.
View All Leaders